Cargando…

Convalescent plasma to treat COVID-19: Following the Argentinian lead

Detalles Bibliográficos
Autores principales:	Tiberghien, Pierre, Toussirot, Eric, Richard, Pascale, Morel, Pascal, Garraud, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141263/ https://www.ncbi.nlm.nih.gov/pubmed/34045121 http://dx.doi.org/10.1016/j.transci.2021.103161

Ejemplares similares

A look-back at convalescent plasma to treat COVID-19
por: Garraud, Olivier, et al.
Publicado: (2021)

L-66 Le plasma convalescent COVID-19 pour le traitement de la COVID-19
por: Tiberghien, Pierre, et al.
Publicado: (2022)

Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology
por: Cognasse, Fabrice, et al.
Publicado: (2022)

Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
por: Garraud, Olivier
Publicado: (2020)

Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps
por: Garraud, O., et al.
Publicado: (2021)

Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans?
por: Garraud, Olivier, et al.
Publicado: (2023)

Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
por: Cognasse, Fabrice, et al.
Publicado: (2022)

Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020)

Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
por: Lacombe, Karine, et al.
Publicado: (2023)

Protocole d’usage thérapeutique du plasma de convalescent de COVID-19–Suivi
por: Fillet, Anne-Marie, et al.
Publicado: (2021)

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial
por: Desmarets, Maxime, et al.
Publicado: (2023)

Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis
por: Hueso, Thomas, et al.
Publicado: (2022)

Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
por: Bloch, Evan M, et al.
Publicado: (2023)

Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients
por: Roshandel, Elham, et al.
Publicado: (2021)

Convalescent plasma to treat COVID-19: clinical experience and efficacy
por: Pei, Shiyao, et al.
Publicado: (2021)

The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors
por: Kroemer, Marie, et al.
Publicado: (2022)

Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
por: Hueso, Thomas, et al.
Publicado: (2020)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection
por: Murphy, Michael, et al.
Publicado: (2020)

Convalescent plasma to treat COVID-19: Its challenges in Iraq's situation
por: Hashim, H.T.
Publicado: (2020)

Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy
por: Rahimi-Levene, Naomi, et al.
Publicado: (2022)

Risk for Hepatitis E Virus Transmission by Solvent/Detergent–Treated Plasma
por: Gallian, Pierre, et al.
Publicado: (2020)

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

Effect of COVID19 pandemic on Argentinian Fabry and Gaucher patients
por: Rozenfeld, Paula A., et al.
Publicado: (2022)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020)

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Convalescent plasma in outpatients with COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Appropriate selection of convalescent plasma donors for COVID-19
por: Tedder, Richard S, et al.
Publicado: (2021)

Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2021)

Behcet Disease in pediatric Argentinian patients
por: Meiorin, S, et al.
Publicado: (2015)

Genetic admixture patterns in Argentinian Patagonia
por: Parolin, María Laura, et al.
Publicado: (2019)

Color Source for the First Argentinian Flags
por: Picone, A. Lorena, et al.
Publicado: (2019)

Experiences of distortions to the passage of time during the Argentinian Covid-19 pandemic
por: Brenlla, María Elena, et al.
Publicado: (2022)

Genome sequence of an aflatoxigenic pathogen of Argentinian peanut, Aspergillus arachidicola
por: Moore, Geromy G., et al.
Publicado: (2018)

Therapeutic plasma exchange followed by convalescent plasma transfusion in critical COVID-19—An exploratory study
por: Jaiswal, Vinod, et al.
Publicado: (2021)

Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)

Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)

Donating convalescent plasma for COVID-19 patients
por: Black, Emily
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p7961rf5b9q4dnjocokpk98jtq